The primary outcome was the use of CA-125 testing and CT scans in the first year after remission (Cohort 1). We also examined patient factors associated with testing. Secondary outcomes included: (1) time to retreatment with chemotherapy or radiation after a documented CA-125 doubling (Cohort 2), and (2) the costs associated with surveillance testing using 2016 Medicare reimbursement rates.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Tips for asking effective questions
+ Description
Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.